ARCALIS, Inc.

Exhibitors

Information

ARCALIS is a CDMO specializing in messenger RNA (mRNA) Medicines & Vaccines. Founded as a joint venture between Axcelead, Inc., Japan's first drug discovery platform company, and Arcturus Therapeutics, a US-based clinical mRNA medicines company.In July 2023, ARCALIS established a GMP mRNA drug substance manufacturing facility in Japan, further strengthening our capabilities. In 2024, we achiev...
Organization Type
CMO/CDMO
Business Activity
Contract Manufacturer
Company Certification
GMP
Markets Active In
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countries
Country
Japan
Products and Services
Anatomical Therapeutic Chemical (ATC) Classification ProductsBiopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Product Types
Biopharmaceutical ProductsAnatomical Therapeutic Chemical (ATC) Classification Products
Service Types
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Product Categories
Chemistry, Manufacturing and Controls (CMC)Tech transfer and Scale upAntiinfectives for Systemic use

Social media

Contact details

https://corp.arcalis.co.jp/en
Japan

Products

Sessions

Building a Robust mRNA CDMO: Advancing Scalable and End-to-End Manufacturing Solutions

Tuesday, May 20, 2025 3:35 PM to 3:50 PM
Innovation Theater
Satoshi Takamatsu · ARCALIS, Inc.

Team

HY
Hideki Yoshihisa
Head of Sales and MarketingARCALIS, Inc.
Satoshi Takamatsu
Satoshi Takamatsu
Representative Director, President and CEOARCALIS, Inc.

Log in

See all the content and easy-to-use features by logging in or registering!